CSPC Innovation Pharmaceutical Co., Ltd. announced that it has received CNY 499.999998 million in funding from a group of investors
The transaction included participation from Caitong Fund Management Co., Ltd. for 6,347,607 shares for CNY 100,799,999.16; UBS AG, Investment Arm for 3,211,586 shares for CNY 50,999,985.68; Ruihua Selected No. 8 Private Equity Securities Investment Fund, a fund managed by Jiangsu Ruihua Investment Management Co., Ltd. for 3,211,586 shares for CNY 50,999,985.68; Nuode Asset Management Co., Ltd. for 2,021,410 shares for CNY 32,099,990.80; Hunan Light Salt Venture Capital Management Co., Ltd. for 2,013,224 shares for CNY 31,969,997.12; Jinan Hanxiang Investment Management Partnership Enterprise (Limited Partnership) for 1,889,168 shares for CNY 29,999,987.84; Jiangxi Chinese Media Lanhai International Investment Co., Ltd. for 1,889,168 shares for CNY 29,999,987.84; Guodu Venture Capital Co., Ltd. for 1,574,307 shares for CNY 24,999,995.16; Danyin Juhu Private Securities Investment Fund, a fund managed by Shanghai Danyin Investment Management Center (limited partnership) for 1,259,445 shares for CNY 19,999,986.60; Ping An Fund Management Co., Ltd. for 1,141,696 shares for CNY 18,130,132.48; AEGON-Industrial Fund Management Co., Ltd. for 1,070,528 shares for CNY 16,999,984.64; Nanfang Tianchen (Beijing) Investment Managentment Co., Ltd. for 944,584 shares for CNY 14,999,993.92; CCB Principal Asset Management Co., Ltd. for 944,584 shares for CNY 14,999,993.92; Fengtu Fengtai No. 3 Private Equity Investment Fund, a fund managed by Ningbo Meishan Bonded Port Area Fengtu Investment Management Co., Ltd. for 944,584 shares for CNY 14,999,993.92; Zhang Jianfei for 2,021,410 shares for CNY 32,099,990.80; and Fang Shaikui for 944,584 shares for CNY 14,999,993.92.